Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised €11M Series A (Jan 2026). FDA-cleared in 2025. Detects 96%+ of congenital heart defects in prenatal ultrasound. Distributed via GE HealthCare Voluson platform.
BrightHeart is a medical AI company developing prenatal diagnostic tools for detecting congenital heart defects (CHD) — the most common birth defect globally — through standard obstetric ultrasound. The company raised €11 million ($12 million) in Series A financing in January 2026 and achieved five FDA clearances in 2025 ahead of US commercial launch, with distribution through GE HealthCare's Voluson ultrasound platform.
Llama 4 open-source model (Scout, Maverick, Behemoth) released March 2026; Meta AI assistant deployed to 700M+ users across WhatsApp, Instagram, Facebook. FAIR research driving multimodal AI advances; $35B AI capex in 2025.
Meta Platforms is a Menlo Park, California-based technology conglomerate operating the world's most widely used social media ecosystem — Facebook (3+ billion monthly active users), Instagram (2+ billion MAU), WhatsApp (2.8+ billion MAU), and Threads (launched 2023) — while investing heavily in virtual reality hardware (Meta Quest), augmented reality glasses (Meta Ray-Ban, Orion AR glasses in development), and AI research (Llama open-source model family). Listed on NASDAQ (NASDAQ: META), Meta generated $164.5 billion in revenue in fiscal year 2024 and employs approximately 74,000 people globally.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.